Has Daniel Fulkerson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $91,818 in general payments to Daniel Fulkerson, MD across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Fulkerson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Fulkerson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Fulkerson, MD

Neurological Surgery · South Bend, INNPI 1386802387

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $70,399 of the $91,818 with a category attached, or 76.7%. Aesculap, Inc. accounts for 78.1% of it on its own, with 31 other manufacturers making up the rest. Among neurological surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$91,818in general payments, 2019–2025

Across 157 payments — averaging $584.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aesculap, Inc.$72K
Aesculap Implant Systems, LLC$16K
Medtronic$3K
Providence Medical Technology, Inc.$283
Alphatec Spine, Inc$209
Orthofix Medical, Inc.$205
plus $1K from 26 others

What the payments were for

Consulting fees$70,39977%
Speaking & faculty fees$8,6549%
Travel & lodging$8,95410%
Food & beverage$3,7744%
Education$380%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aesculap, Inc.	76	$71,686
Aesculap Implant Systems, LLC	1	$15,563
Medtronic(2 entities)	13	$2,775
Providence Medical Technology, Inc.	3	$283
Alphatec Spine, Inc	3	$209
Orthofix Medical, Inc.	9	$205
Integra Lifesciences Corporation	9	$186
Si-bone, Inc.	4	$122
AstraZeneca	4	$72
Zimmer Biomet	4	$70
Stryker	3	$64
Spineology Inc.	2	$46
Bioventus LLC	1	$39
Kls-martin L.p.	2	$38
Baxter Healthcare	1	$37
Portola Pharmaceuticals, LLC	2	$36
Livanova USA, Inc.	2	$36
Expanding Innovations, Inc.	1	$35
DJO, LLC	2	$33
UCB, Inc.	2	$33
Globus Medical	1	$32
Surgalign Spine Technologies, Inc.	1	$31
Sunovion Pharmaceuticals Inc.	2	$29
Kerecis Limited	1	$27
AbbVie	1	$21
CSL Behring	1	$20
Nevro Corp.	1	$20
Merck	1	$18
Johnson & Johnson	1	$16
Boston Scientific	1	$14
Adamas Pharmaceuticals, Inc.	1	$13
Arbor Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROGAV 2.0$55,412
XABO$16,865
AESCULAP$8,977
MINOP MODULAR NEUROENDOSCOPY SYSTEM$3,383
MazorX - Renaissance$1,277
CD HORIZON$1,018
NO APPLICABLE MARKETED PRODUCT NAME$853
PAEDIGAV$558
Other - Miscellaneous$106

How this compares

$91,818 in reported general payments places this provider in the 90th percentile of 112 neurological surgery providers in Indiana.

See all neurological surgery providers in Indiana →

Medicare billing

Part B allowed, 2024

$54,434

Medicare patients

139

Services billed

246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in South Bend

Richard FesslerSouth Bend$33K
Stephen SmithSouth Bend$31K
Walter LangheinrichSouth Bend$16K
Neal PatelSouth Bend$12K
Osmond WuSouth Bend$6K
Jean-Pierre MobasserCarmel$3.5M
Troy PaynerCarmel$803K
Michael TurnerIndianapolis$522K
Eric PottsCarmel$345K
Souheil HaddadBloomington$161K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →